Bausch + Lomb Corporation
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BLCO research report →
Companywww.bausch.com
Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products, over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions comprising eye allergies, conjunctivitis, and dry eye.
- CEO
- Brenton L. Saunders
- IPO
- 2022
- Employees
- 13,500
- HQ
- Vaughan, ON, CA
Price Chart
Valuation
- Market Cap
- $5.78B
- P/E
- -26.28
- P/S
- 1.11
- P/B
- 0.90
- EV/EBITDA
- 7.66
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 55.86%
- Op Margin
- 5.91%
- Net Margin
- -4.21%
- ROE
- -3.41%
- ROIC
- 2.57%
Growth & Income
- Revenue
- $5.10B · 6.47%
- Net Income
- $-360,000,000 · -13.56%
- EPS
- $-1.02 · -13.33%
- Op Income
- $188.00M
- FCF YoY
- -11.86%
Performance & Tape
- 52W High
- $18.91
- 52W Low
- $10.99
- 50D MA
- $16.20
- 200D MA
- $16.02
- Beta
- 0.59
- Avg Volume
- 446.44K
Get TickerSpark's AI analysis on BLCO
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 5, 26 | Eldessouky Sam | other | 63,938 |
| May 5, 26 | Hashad Yehia | other | 13,664 |
| May 5, 26 | Munsch Frederick | other | 8,673 |
| May 5, 26 | Bonnefoy Luc | other | 11,970 |
| Apr 30, 26 | ROBERTSON RUSSEL C | other | 1,611 |
| Apr 30, 26 | Paulson John | other | 1,375 |
| Apr 30, 26 | COLLIS STEVEN H | other | 1,415 |
| Apr 30, 26 | Alfonso Eduardo | other | 1,375 |
| Apr 24, 26 | Stewart Andrew J. | other | 4,216 |
| Apr 24, 26 | Bailey A Robert D | other | 15,806 |
Our BLCO Coverage
We haven't published any research on BLCO yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate BLCO Report →